Ophiuchus Technologies AG
Developing regenerative cell technology for the treatment of injured brain and spinal cord tissue
Ophiuchus Technologies is committed to developing its proprietary regenerative cell technology, DrSC™ Neural in order to provide physicians with a new and efficient tool for the treatment and functional restoration of injured brain and spinal cord tissue.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
No Awards
Ophiuchus Technologies AG
Developing regenerative cell technology for the treatment of injured brain and spinal cord tissue
Website:
www.ophiuchustechnologies.com
Headquarter:
Root D4
Foundation Date:
June 2013
Technology:
- Biotech